Skip to main content

Table 2 Relevant validation information for genes (UPF2 and NUCB2) passed CNV QC and signal intensity examination

From: Genomic copy number variation association study in Caucasian patients with nonsyndromic cryptorchidism

Group

Gene Name

CNV (hg19)

Probe # in overlapping CNV region

CNV size (bp)

TaqMan CNV assays and location

Cases with deletion (CNV confidence score)

Group 1

UPF2

chr10:12028228–12076043

10

47815

Hs04383175_cn; Chr10:12063665

D10 (26)a, D29 (55)a, D34 (46), 1495 (27)

 

NUCB2

chr11:17300844–17320797

5

19953

Hs06286795_cn; Chr11:17306162

D8 (24), D10 (28)a, D24 (24), D29 (30)a, D33 (26), D132 (27), D139 (30)

Group 2

UPF2

chr10:12062959–12075960

3

13001

Same as UPF2 assay in group 1

7279 (15), 7334 (12)a, 7338 (23), 7339 (16), 7341 (14), 7370 (26)a, 7453 (16), 7475 (24), 7479 (17)

 

NUCB2

chr11:17332461–17339127

4

6666

Hs06269635_cn; Chr11:17336218

7334 (17)a, 7361 (14), 7370 (12)a

  1. Case IDs with underline: samples tested by TaqMan CNV assays for validation
  2. asamples with called deletions in both genes (UPF2 and NUCB2)